Prophylactic Ablation Warranted In High-Risk WPWS Patients – NEJM Study
This article was originally published in The Gray Sheet
Executive Summary
High-risk Wolff-Parkinson-White syndrome (WPWS) patients should receive prophylactic accessory pathway ablation treatment to prevent arrhythmia, even in cases where the patients are asymptomatic, according to a study in the Nov. 6 New England Journal of Medicine.